The human interferon y receptor has previously been assigned to chromosome 6. Chromosome 6 also encodes HLA, the human class I major histocompatibility antigens. However, the presence of chromosome 6 in hamster-human hybrids is by itself insufficient to confer sensitivity to human immune interferon as measured by the induction of human HLA. Human chromosome 21 was found to be the second chromosome essential for HLA inducibility.Similar results were found with mouse-human somatic cell hybrids. Thus, at least two steps are involved in the action of human interferon y: the binding of interferon Yto its receptor coded by chromosome 6 and the linkage of this binding event through a factor coded by chromosome 21 to trigger biological action. Both of these steps are species-specific.The antiviral action of interferon y (IFN-y) is overshadowed by its ability to mediate a multitude ofother biological effects. IFN-y, by itself or synergizing with lymphotoxins, has much greater cytostatic and cytotoxic effects than IFN-a//3 (1-3).The major histocompatability complex (MHC) antigens are greatly enhanced with IFN-y: the class I human HLA-A, B, C and f-microglobulin (4-6), or the mouse H-2 antigens (7), the class II human HLA-DR, -SB and -DC (8-10), or the mouse Ia antigens (11), and the class III complement and factor B antigens expressed by mononuclear phagocytes (12). Other immunoregulatory effects of IFN-y include its ability to potentiate macrophage cytotoxicity or phagocytosis, possibly through the stimulation of IgG Fc fragment receptors (13-15). IFN-y can also induce the differentiation of myeloid cells into the monocytic pathway (16). The pleiotropic response to IFN-y suggests complex interactions beyond the ligand-receptor binding.We previously reported the localization of the human interferon y (Hu-IFN-y) receptor to chromosome 6 (17-19). Here we report a genetic approach that has begun to unravel this complex system of signal transduction. Initial experiments had indicated that chromosome 6, unlike chromosome 21 and its Hu-IFN-tx// receptor (20), is by itself incapable of conferring biological sensitivity to Hu-IFN-y. The long and short arms of chromosome 6 encode the Hu-IFN-y receptor (17) and the HLA antigens (21), respectively. The presence of human chromosome 6 in a heterologous host, therefore, provides a convenient system to determine whether other chromosomes are necessary to modulate the expression of MHC antigens. Through the use of somatic cell hybrids we have delineated the human chromosomes essential for induction of class I MHC antigens by Hu-IFN-y. EXPERIMENTAL PROCEDURES IFNs, Radiolabeling and Covalent Crosslinking. Recombinant Hu-IFN-aA/D(Bgl) and Hu-IFN-y, with respective specific activities of 1.9 x 108 units/mg and 1 x 107 units/mg were purified from Escherichia coli as described (22-24) by R. Ning, S. J. Tarnowski, C. J. Chen, F. Khan, and J. Langer. Mouse interferon y (Mu-IFN-y) with a specific activity of about 1 x 107 units/mg was a gift from M. Sheppard of Genentech. Antiviral titer...